Molecular Profiling and Targeted Therapeutic Strategies in Breast Cancer: Clinical Integration of HER2, CDK4/6, and PI3K Inhibition with Trastuzumab, Abemaciclib and Alpelisib.
Saved in:
| Title: | Molecular Profiling and Targeted Therapeutic Strategies in Breast Cancer: Clinical Integration of HER2, CDK4/6, and PI3K Inhibition with Trastuzumab, Abemaciclib and Alpelisib. |
|---|---|
| Authors: | Kawczak, Piotr1 (AUTHOR) piotr.kawczak@gumed.edu.pl, Bączek, Tomasz1,2 (AUTHOR) |
| Source: | Journal of Clinical Medicine. May2026, Vol. 15 Issue 10, p3715. 40p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20770383 |
|---|---|
| DOI: | 10.3390/jcm15103715 |
